Back to search

United States· US:71205-150_7c4088ea-921d-440c-ae1c-c473fc381e50

Liothyronine Sodium

A medicinal product containing liothyronine sodium, registered in United States by Proficient Rx LP.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedLiothyronine SodiumATC—REGISTER NO.US:71205-150_7c4088ea…PACKS LISTED6CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
LIOTHYRONINE SODIUM
Manufacturer
Proficient Rx LP
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 6

  • ndc11
    7120515030
    30 TABLET in 1 BOTTLE (71205-150-30)
  • ndc11
    7120515060
    60 TABLET in 1 BOTTLE (71205-150-60)
  • ndc11
    7120515090
    90 TABLET in 1 BOTTLE (71205-150-90)
  • ndc11
    71205-150-30
  • ndc11
    71205-150-60
  • ndc11
    71205-150-90

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Liothyronine sodium in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All liothyronine sodium products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Germany · Thybon 100, Thybon 20
  • Denmark · Liopent
  • France · Cynomel, Thybon
  • United Kingdom (Northern Ireland) · Enolio, Iraksin
  • Greece · T3
  • Italy · Liotir
  • Netherlands · Cytomel, Liopent
  • Norway · Liothyronin Orifarm Healthcare
  • Sweden · Liothyronin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c7a026a2-6cbc-49d3-a52e-a76f0b0ced5d
GET /v1/drugs/c7a026a2-6cbc-49d3-a52e-a76f0b0ced5d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "5",
  "substance": "LIOTHYRONINE SODIUM",
  "productndc": "71205-150",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "ug/1",
  "application_number": "ANDA200295",
  "marketing_category": "ANDA"
}

See everything about liothyronine sodium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.